Masataka Minami

USPTO Granted Patents = 5 (Patent Applications = 3)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 9.4

ph-index = 1

Forward Citations = 9(Granted Patents)

Company Filing History:

4 out of 1,235

Nissan Chemical Industries Limited

patents

1 out of 213

Nissan Chemical Corporation

patents

1 out of 947

Chugai Seiyaku Kabushiki Kaisha

patents

where one patent can have more than one assignee

Years Active: 2011-2019

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10385052 - Tricyclic compound and JAK inhibitor (2019-08-20),

2. 9890165 - Tricyclic compound and JAK inhibitor (2018-02-13),

3. 9556187 - Substituted pyrrolo[3',2′:5,6]pyrido[4,3-d]pyrimidines and JAK inhibitors comprising the same (2017-01-31),

4. 9216999 - Substituted pyrrolo[2,3-h][1,6]naphthyridines and compositions thereof as JAK inhibitors (2015-12-22),

5. 7879887 - α-amino acid derivatives and medicaments containing the same as an active ingredient (2011-02-01),

Title: Masataka Minami: Innovator in Tricyclic Compounds

Introduction

Masataka Minami is a notable inventor based in Funabashi, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel tricyclic compounds. With a total of 5 patents to his name, Minami's work focuses on innovative solutions for various medical conditions.

Latest Patents

Among his latest patents, Minami has developed tricyclic compounds that exhibit JAK inhibitory activities. These compounds are particularly useful for the prevention, treatment, or improvement of autoimmune diseases, inflammatory diseases, and allergic diseases. The novel tricyclic compounds are represented by specific chemical formulas, where each component is carefully designed to enhance their therapeutic efficacy.

Career Highlights

Minami has worked with prominent companies in the chemical industry, including Nissan Chemical Industries Limited and Nissan Chemical Corporation. His experience in these organizations has allowed him to refine his expertise in chemical innovation and patent development.

Collaborations

Some of his notable coworkers include Keishi Hayashi and Tsuneo Watanabe. Their collaborative efforts have contributed to the advancement of research in the field of medicinal chemistry.

Conclusion

Masataka Minami's innovative work in tricyclic compounds showcases his dedication to improving healthcare solutions. His patents reflect a commitment to addressing complex medical challenges through scientific innovation.

This text is generated by artificial intelligence and may not be accurate.